NVST · Envista Holdings Corp
Market Cap
$4.38B
Shares
160.62M
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Revenue
$2.72B
+8.3%
FY2025
Net Income
$47M
+104.2%
FY2025
Gross Margin
54.67%
0pp
FY2025
Operating Margin
7.95%
+49.3pp
FY2025
Diluted EPS
$0.28
+104.3%
FY2025
Operating Cash Flow
$275.7M
-18.1%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| $2.86B | $2.72B | $2.51B | $2.57B | $2.57B | $2.51B | $1.93B | $2.28B | $2.84B | $2.81B | |
| $1.28B | $1.23B | $1.14B | $1.13B | $1.09B | $1.08B | $874.3M | $935.6M | $1.24B | $1.19B | |
| $1.58B | $1.49B | $1.37B | $1.44B | $1.47B | $1.43B | $1.05B | $1.35B | $1.6B | $1.62B | |
| — | 54.67% | 54.68% | 56.13% | 57.41% | 56.86% | 54.68% | 59.05% | 56.31% | 57.68% | |
| $120.8M | $114M | $99.1M | $93.8M | $100.1M | $100.5M | $86.7M | $133.1M | $172M | $172.4M | |
| $1.18B | $1.16B | $1.16B | $1.06B | $1.06B | $1.02B | $924.6M | $980.4M | $1.13B | $1.06B | |
| — | $75.9M | $82.3M | $99.6M | $106M | $81.5M | $87.3M | $85.5M | $90.6M | $82M | |
| $115.3M | $116M | $123.1M | $135.6M | $137.8M | $117.8M | $121.7M | $120.4M | $130M | $121.4M | |
| — | $0 | $0 | $1.3M | $4.7M | $10.8M | $89.3M | $13M | $23.7M | $35.8M | |
| — | — | $2.27B | $2.18B | $2.13B | — | — | — | — | — | |
| $273.6M | $216.1M | -$1.04B | $31.5M | $319.2M | $306.2M | $43.5M | $235.7M | $298.4M | $386.6M | |
| — | 7.95% | -41.35% | 1.23% | 12.42% | 12.2% | 2.25% | 10.32% | 10.49% | 13.75% | |
| $388.9M | $332.1M | -$915.1M | $167.1M | $457M | $424M | $165.2M | $356.1M | $428.4M | $508M | |
| $53.9M | — | — | $63.4M | $38.4M | $54.1M | $62.5M | $3.5M | $0 | $0 | |
| -$4.1M | -$2.3M | -$100K | -$23M | $3.1M | $2.4M | -$1M | $1.5M | $2.7M | — | |
| -$8.2M | -$6.2M | -$1.1M | $3.6M | $0 | — | — | — | — | — | |
| $234.1M | $177.2M | -$1.08B | -$54.9M | $283.9M | $254.5M | -$20M | $233.7M | $301.1M | $386.7M | |
| $139.1M | $130.2M | $33.9M | $45.3M | $45.9M | -$9M | -$62.5M | $49.6M | $70.4M | $85.6M | |
| $95M | $47M | -$1.12B | -$100.2M | $243.1M | $340.5M | $33.3M | $217.6M | $230.7M | $301.1M | |
| — | 1.73% | -44.56% | -3.9% | 9.46% | 13.57% | 1.73% | 9.52% | 8.11% | 10.71% | |
| $68.6M | $304.9M | -$1.27B | -$92.3M | $161.5M | $288.8M | $85.7M | $151.6M | $152.1M | $549.4M | |
| USD/shares | $0.59 | $0.28 | -$6.50 | -$0.60 | $1.49 | $2.11 | $0.21 | $1.60 | $1.80 | $2.35 |
| USD/shares | $0.58 | $0.28 | -$6.50 | -$0.60 | $1.37 | $1.92 | $0.20 | $1.60 | $1.80 | $2.35 |
| shares | — | 168M | 172.2M | 166.9M | 162.9M | 161.2M | 159.6M | 136.2M | 127.9M | 127.9M |
| shares | — | 169.2M | 172.2M | 166.9M | 177.6M | 177.6M | 164.1M | 136.4M | 127.9M | 127.9M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Debt Profile
Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Debt data is being processed. Please check back later.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
1.62×
Peer median 3.57×
EV/EBIT
16.88×
Peer median 34.68×
P/E (TTM)
47.03×
Peer median 36.87×
Peer medians compare against the 24 similar-size Medical Instruments & Supplies companies (of 46 listed).
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Specialty Products and Technologies | $1,752,800,000 | $1,616,400,000 | $1,642,400,000 | $1,598,600,000 | $1,507,800,000 | $1,117,300,000 | $1,342,700,000 | $1,369,800,000 |
| Equipment and Consumables | $966,700,000 | $894,200,000 | $924,100,000 | $970,500,000 | $1,001,100,000 | $811,800,000 | $942,100,000 | $1,474,700,000 |
By Geography (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| North America | $1,395,200,000 | $1,305,300,000 | — | — | — | — | — | — |
| Western Europe | $615,300,000 | $546,000,000 | — | — | — | — | — | — |
| High Growth Markets | $586,200,000 | $539,000,000 | — | — | — | — | — | — |
| Other Developed Markets | $122,800,000 | $120,300,000 | — | — | — | — | — | — |
| China | — | — | $205,700,000 | $222,200,000 | $236,700,000 | $198,200,000 | $189,000,000 | $187,900,000 |
| Germany | — | — | — | — | — | — | — | $164,700,000 |
| United States | — | — | $1,209,400,000 | $1,261,900,000 | $1,223,400,000 | $960,100,000 | $1,098,800,000 | $1,240,500,000 |
| All Other Countries | — | — | $1,151,400,000 | $1,085,000,000 | $1,048,800,000 | $770,800,000 | $997,000,000 | $1,251,400,000 |
By Product & Service (USD)
| Component | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|
| Consumables | $2,147,500,000 | $2,067,900,000 | $1,590,700,000 | $1,866,100,000 | $1,914,800,000 | $1,864,700,000 |
| Equipment Sales | $421,600,000 | $441,000,000 | $338,400,000 | $418,700,000 | $929,700,000 | $946,200,000 |
Segment Operating Income
Annual operating income by business segment, as tagged in the company's own XBRL filings. Segments need not sum to the consolidated figure — corporate costs and eliminations are typically unallocated.
By Segment (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Specialty Products and Technologies | $191,200,000 | $89,900,000 | $232,100,000 | $268,600,000 | $272,300,000 | $65,800,000 | $218,300,000 | $241,300,000 |
| Equipment and Consumables | $158,000,000 | $152,300,000 | $156,300,000 | $172,400,000 | $153,800,000 | $53,600,000 | $73,400,000 | $120,500,000 |
Operating Margin by Segment (%)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Specialty Products and Technologies | 10.9% | 5.6% | 14.1% | 16.8% | 18.1% | 5.9% | 16.3% | 17.6% |
| Equipment and Consumables | 16.3% | 17% | 16.9% | 17.8% | 15.4% | 6.6% | 7.8% | 8.2% |
Key facts
CIK
1757073
CUSIP
29415F104
13F (30d)
223 filings
222 filers
Visit website
Investor relations